Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease - PubMed (original) (raw)
. 1993 Aug;43(8):1467-72.
doi: 10.1212/wnl.43.8.1467.
Affiliations
- PMID: 8350998
- DOI: 10.1212/wnl.43.8.1467
Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease
A M Saunders et al. Neurology. 1993 Aug.
Abstract
Apolipoprotein E, type epsilon 4 allele (APOE epsilon 4), is associated with late-onset familial Alzheimer's disease (AD). There is high avidity and specific binding of amyloid beta-peptide with the protein ApoE. To test the hypothesis that late-onset familial AD may represent the clustering of sporadic AD in families large enough to be studied, we extended the analyses of APOE alleles to several series of sporadic AD patients. APOE epsilon 4 is significantly associated with a series of probable sporadic AD patients (0.36 +/- 0.042, AD, versus 0.16 +/- 0.027, controls [allele frequency estimate +/- standard error], p = 0.00031). Spouse controls did not differ from CEPH grandparent controls from the Centre d'Etude du Polymorphisme Humain (CEPH) or from literature controls. A large combined series of autopsy-documented sporadic AD patients also demonstrated highly significant association with the APOE epsilon 4 allele (0.40 +/- 0.026, p < or = 0.00001). These data support the involvement of ApoE epsilon 4 in the pathogenesis of late-onset familial and sporadic AD. ApoE isoforms may play an important role in the metabolism of beta-peptide, and APOE epsilon 4 may operate as a susceptibility gene (risk factor) for the clinical expression of AD.
Comment in
- Apolipoprotein E epsilon 4.
Sakoda S, Kuriyama M, Osame M, Takahashi K, Yamano T, Sasaki J, Matsunaga A. Sakoda S, et al. Neurology. 1994 Dec;44(12):2420; author reply 2421. doi: 10.1212/wnl.44.12.2420. Neurology. 1994. PMID: 7991153 No abstract available. - Apolipoprotein E epsilon 4.
Rama Krishnan KR, Ritchie JC Jr, Tupler LA, McDonald WM, Knight D, Nemeroff CB, Marcovina S. Rama Krishnan KR, et al. Neurology. 1994 Dec;44(12):2420-1. doi: 10.1212/wnl.44.12.2420-a. Neurology. 1994. PMID: 7991154 No abstract available.
Similar articles
- ApoE allele frequencies in Italian sporadic and familial Alzheimer's disease.
Sorbi S, Nacmias B, Forleo P, Latorraca S, Gobbini I, Bracco L, Piacentini S, Amaducci L. Sorbi S, et al. Neurosci Lett. 1994 Aug 15;177(1-2):100-2. doi: 10.1016/0304-3940(94)90054-x. Neurosci Lett. 1994. PMID: 7824157 - Apolipoprotein E polymorphism and Alzheimer's disease.
Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S. Poirier J, et al. Lancet. 1993 Sep 18;342(8873):697-9. doi: 10.1016/0140-6736(93)91705-q. Lancet. 1993. PMID: 8103819 - Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease.
Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC Jr, Rimmler JB, Locke PA, Conneally PM, Schmader KE, et al. Corder EH, et al. Nat Genet. 1994 Jun;7(2):180-4. doi: 10.1038/ng0694-180. Nat Genet. 1994. PMID: 7920638 - [Lipoproteins in clinical laboratory medicine].
Kuriyama M. Kuriyama M. Rinsho Byori. 1998 Dec;46(12):1219-25. Rinsho Byori. 1998. PMID: 9916507 Review. Japanese. - [Apolipoprotein E4 and late-onset Alzheimer's disease].
Tamaoka A. Tamaoka A. Nihon Rinsho. 1994 Dec;52(12):3257-65. Nihon Rinsho. 1994. PMID: 7853720 Review. Japanese.
Cited by
- Updates in Alzheimer's disease: from basic research to diagnosis and therapies.
Liu E, Zhang Y, Wang JZ. Liu E, et al. Transl Neurodegener. 2024 Sep 4;13(1):45. doi: 10.1186/s40035-024-00432-x. Transl Neurodegener. 2024. PMID: 39232848 Free PMC article. Review. - CRISPR/Cas9 gene editing: New hope for Alzheimer's disease therapeutics.
Bhardwaj S, Kesari KK, Rachamalla M, Mani S, Ashraf GM, Jha SK, Kumar P, Ambasta RK, Dureja H, Devkota HP, Gupta G, Chellappan DK, Singh SK, Dua K, Ruokolainen J, Kamal MA, Ojha S, Jha NK. Bhardwaj S, et al. J Adv Res. 2022 Sep;40:207-221. doi: 10.1016/j.jare.2021.07.001. Epub 2021 Jul 6. J Adv Res. 2022. PMID: 36100328 Free PMC article. Review. - Suppression of Wnt/β-Catenin Signaling Is Associated with Downregulation of Wnt1, PORCN, and Rspo2 in Alzheimer's Disease.
Macyczko JR, Wang N, Zhao J, Ren Y, Lu W, Ikezu TC, Zhao N, Liu CC, Bu G, Li Y. Macyczko JR, et al. Mol Neurobiol. 2023 Jan;60(1):26-35. doi: 10.1007/s12035-022-03065-1. Epub 2022 Oct 10. Mol Neurobiol. 2023. PMID: 36215026 Free PMC article. - Association of plasma and cortical amyloid beta is modulated by APOE ε4 status.
Swaminathan S, Risacher SL, Yoder KK, West JD, Shen L, Kim S, Inlow M, Foroud T, Jagust WJ, Koeppe RA, Mathis CA, Shaw LM, Trojanowski JQ, Soares H, Aisen PS, Petersen RC, Weiner MW, Saykin AJ; Alzheimer's Disease Neuroimaging Initiative. Swaminathan S, et al. Alzheimers Dement. 2014 Jan;10(1):e9-e18. doi: 10.1016/j.jalz.2013.01.007. Epub 2013 Mar 26. Alzheimers Dement. 2014. PMID: 23541187 Free PMC article. - Past and future episodic detail retrieval is reduced among clinically normal older adults at higher genetic risk for late-onset Alzheimer's disease.
Acevedo-Molina MC, Thayer SC, Horn K, Nkulu H, Ryan L, Andrews-Hanna JR, Grilli MD. Acevedo-Molina MC, et al. Neuropsychology. 2023 Feb;37(2):194-203. doi: 10.1037/neu0000866. Epub 2022 Nov 28. Neuropsychology. 2023. PMID: 36442007 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous